Presentation TCT 2013 Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial Presenter: Gregg Stone October 30, 2013
Presentation TCT 2013 Case Presentation Conclusion: Procedural and Patient Outcomes Presenter: Divaka Perera October 30, 2013
Presentation TCT 2013 Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies Presenter: Jodi Akin October 30, 2013
Presentation TCT 2013 TCT-123. Preliminary safety and efficacy results from the REALISE trial: REnAL denervatIon by ultraSound transcatheter Emission Presenter: Gilles Montalescot October 30, 2013
Presentation TCT 2013 Climbing the Academic Ladder: Pitfalls and Triumphs Presenter: J. Dawn Abbott October 30, 2013
Presentation TCT 2013 Primary PCI for STEMI: A Resounding Victory and Future Challenges Presenter: Gregg Stone October 30, 2013
Presentation TCT 2013 Navigating the Stent Era (from Bare Metal to Drug-Eluting): The Transformation of PCI Presenter: Patrick Serruys October 30, 2013
Presentation TCT 2013 CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI Presenter: David Erlinge October 30, 2013
Presentation TCT 2013 Are Sham Controls Needed for Future Renal Denervation Studies? Presenter: Ajay Kirtane October 30, 2013